home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

7th Annual Proteins & Antibodies Congress

 
  October 01, 2013  
     
 
Oxford Global, Novotel London West, One Shortlands, London, W6 8DR
3rd & 4th April 2014


The Event

In keeping with Oxford Global’s highly successful life sciences series, an expert panel of 40 speakers will present a full conference programme covering the topics outlined below. These topics have been compiled as a result of a comprehensive research process undertaken with over 20 advisory board members including VPs, Directors, Senior Research Fellows and Professors from global pharmaceutical organisations and leading research institutions.

-

Stream Titles

Antibody Discovery & Development

Protein Purification, Expression & Characterisation

Antibody Engineering

Biotherapeutics Optimisation

-

Day 1 Stream 1 – Antibody Discovery & Development

  • Developing Next Generation Antibodies
  • Primary And Secondary Antibody Selection
  • Advances In Antibody Screening Technologies
  • Cost Effective And Time Efficient Production Strategies
  • High-Throughput Glycan Profiling
  • Case Study: Generating Antibodies Using Mammalian Cells

Day 1 Stream 2 – Protein Expression, Purification & Characterisation

  • Advances In Characterisation Platforms And Processes
  • Protein Purification Tools To Enable Crystallisation
  • Protein Assay Methods: Producing Reliable Results
  • Overcoming The Challenges In Protein Folding
  • Cell Line Selection For Maximum Protein Production
  • Vector Design For Optimal Protein Expression

Day 2 Stream 1 – Engineered Antibodies

  • Case Studies: Increasing Clinical Success Rate
  • Accelerated Formulation Strategies
  • Armed Antibodies: Targeting Difficult Receptors
  • Novel Technologies In Antibody Engineering
  • Monoclonal Bispecific Antibodies In Cancer Therapy
  • Antibody-Cytokine Fusions: Opportunities And Applications

Day 2 Steam 2 – Biotherapeutics Optimisation

  • Case Studies: Limitations And Advantages Of PEGylation
  • Selecting The Optimal Biotherapeutic Candidate
  • Immunogenicity And Safety Testing Of Complex Proteins
  • Overcoming Aggregation And Stability Challenges In Downstream Processing
  • Extending Half-Life Of Biologics
  • Alternative Scaffolds For Novel Proteins
 
 
Organized by: Oxford Global Conferences
Invited Speakers:

·  Martin Bader
Head of Protein Chemistry, Roche

·  Caroline Barelle
Research Director VNRA Development, University of Aberdeen

·  Andreas Baumann
Director, Principal Scientific Expert Biologics, Bayer

·  Simon Brack
Director Discovery Research, Covagen

·  Steven Coats
Senior Director R&D, MedImmune

·  Gerhardus de Jong
Professor Biomolecular Analysis, Ultrecht University

·  Rakesh Dixit
VP R&D Head Biologics Safety Assessment, MedImmune

·  Claire Dobson
Associate Director, Antibody Discovery & Protein Engineering, MedImmune

·  William Finlay
Director Protein Discovery and Optimisation, Global Biotherapeutics Director, Pfizer

·  Patrick Garidel
Head of Biopharmaceutical Basic Development, Boehringer Ingelheim

 
Deadline for Abstracts: NA
 
Registration: For more information and to register: www.proteins-congress.com/download-agenda-marketing
E-mail: d.dalby@oxfordglobal.co.uk
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.